Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials

Item

http://www.wikidata.org/entity/Q36712221

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@ast

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@en

type

Item

label

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@ast

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@en

prefLabel

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@ast

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@en

P1476

Cystatin C- and Creatinine-Bas ...... flozin Phase 3 Clinical Trials

@en

P2093

Arie Katz

http://www.w3.org/2001/XMLSchema#string

Christian Mende

http://www.w3.org/2001/XMLSchema#string

P2860

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Established and emerging markers of kidney function

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.

Cystatin C identifies chronic kidney disease patients at higher risk for complications.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease.

Measured GFR as a confirmatory test for estimated GFR.

Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations.

Estimating glomerular filtration rate from serum creatinine and cystatin C.

P2888

s13300-016-0158-y

P304

139-151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-016-0158-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295689218

http://www.w3.org/2001/XMLSchema#string

P698

26899432

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

4801818

http://www.w3.org/2001/XMLSchema#string